[2 MIN READ]
This article is part of a paid branded content series with Get Creative, a division of USA Today. The article originally appeared on USA Today here.
One of the things that makes cancer so frightening is that its causes are so often unknown or out of our control. With colorectal cancer, though, much is within our control.
While tobacco is by far the leading cause of lung cancer, it's not the only contributor. Learn about other significant risk factors and what you can do to protect yourself and your loved ones.
Early lung cancer screening and quitting smoking saves lives.
Researchers at the Earle A. Chiles Research Institute, a division of Providence Cancer Institute in Portland, Oregon, joined leading cancer immunotherapy professionals around the world for the largest
Getting over your fears gets you more than halfway to your colonoscopy appointment. Here are some common myths.
A Providence provider answers frequently asked questions about polyps.
During Breast Cancer Awareness month schedule genetic testing.
Providence Cancer Institute breast cancer experts are researching new treatments for women with triple-negative breast cancer and HER-2 positive breast cancer.
Navigating cancer treatments is overwhelming at any time, but especially during a pandemic. Get the facts about your risk of COVID-19.
Research studies and treatments at Providence lead the way in breakthroughs for pediatric cancer patients.
Providence Sacred Heart Hospital provides holistic care and support programs for children with cancer and their loved ones.
Experts in biomedical engineering, immunology and surgical oncology are working collaboratively to improve outcomes for people with head, neck and other cancers.
Providence Cancer Institute to open new clinical study of CAR T-cell therapy to people with clear cell renal cell carcinoma, the most common type of kidney cancer.
Comprehensive genomic profiling is driving innovation and changing diagnostics across Providence's 51-hospital system.
First-in-human immune therapy study at Providence Cancer Institute will assess the safety and effectiveness of talquetamab as a potential treatment for cancerous plasma cells known as multiple myeloma
A Providence registered dietitian discusses common cancer nutrition myths and whether certain foods affect your cancer prognosis.
Learn about diverticular disease and how colorectal surgery from Providence helped one diverticulitis patient eliminate the pain she'd lived with for months.
Dr. Gordon of Providence offers an expert perspective on how genomics and genetics are driving the future of personalized care. Learn more.
Learn how the Providence Thrivorship program offers one-on-one counseling and free classes on holistic wellness and nutrition.
Providence researchers awarded funding from National Cancer Institute to study “Bugs as Drugs.”